Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,373.00
+35.00 (2.62%)
At close: Aug 7, 2026

Precision Biosensor Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
22,33619,92619,13420,39120,45815,887
Revenue Growth
14.03%4.14%-6.17%-0.33%28.77%82.93%
Gross Profit
8,0366,4206,1827,6866,7554,605
Operating Income
-3,860-5,381-5,366-4,811-4,500-4,269
Net Income
-7,874-10,023-7,305-4,490-6,806-4,152
Earnings Per Share
-530.71-794.04-629.00-387.00-590.47-368.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11,58310,4273,8186,5178,65022,683
Total Debt
14,24414,62417,66320,29916,5559,652
Net Cash (Debt)
-2,661-4,197-13,845-13,783-7,90413,032
Net Cash Growth
------43.30%
Net Cash Per Share
-179.36-332.53-1192.10-1187.80-685.771154.32

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-811.58-1,513-1,444-1,953-2,576-4,575
Capital Expenditures
-183.76-157.43-64.96-7,053-11,142-9,151
Free Cash Flow
-995.33-1,670-1,509-9,006-13,719-13,726
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.98%32.22%32.31%37.69%33.02%28.98%
Operating Margin
-17.28%-27.01%-28.04%-23.59%-22.00%-26.87%
Pretax Margin
-35.17%-50.20%-36.42%-26.40%-34.24%-26.94%
Profit Margin
-35.25%-50.30%-38.18%-22.02%-33.27%-26.14%
FCF Margin
-4.46%-8.38%-7.89%-44.17%-67.06%-86.40%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.352.391.722.723.367.94